Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis.
about
Effects of lornoxicam on the physiology of severe sepsisCyclooxygenase inhibition in sepsis: is there life after death?Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomalleiPlatelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway.Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestinsIL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins.Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection.Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.Blockade of CD137 signaling counteracts polymicrobial sepsis induced by cecal ligation and puncture.Elevated cardiac troponins in setting of systemic inflammatory response syndrome, sepsis, and septic shockFood Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity.COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression.Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.Perinatal Endotoxemia Induces Sustained Hepatic COX-2 Expression through an NFκB-Dependent Mechanism.Liver X Receptor Gene Expression is Enhanced in Children with Obstructive Sleep Apnea-Hyperpnoea Syndrome and Cyclooxygenase-2 (COX-2) is Correlated with Severity of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS).Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis.Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice.Disruption of COX-2 and eNOS does not confer protection from cardiovascular failure in lipopolysaccharide-treated conscious mice and isolated vascular rings.
P2860
Q24801307-6124235B-555C-4DBD-BF62-4D0B5AB53233Q27024316-2867C329-33D7-4FDA-A185-F03FF1ACB731Q27305217-1798E603-6606-4F89-990B-B7A2546E970DQ33411077-BCDC8E7C-9E73-41FE-B4CA-08AF4742F058Q34091848-47BC49BF-63AD-4935-BB0D-0C35701E19CCQ35083565-8D59FFE8-4F17-48C6-A775-D73860856876Q35523910-1CB2AA5B-2B0C-4D2C-B5B7-EA5A08C8B515Q35665775-2B22BA99-E6AE-4F44-8BB1-5B246EDA0D99Q36605944-36C72382-0E64-47BF-BE89-A88EBC9CF289Q36707403-139D6E4D-F957-4A9A-8648-BF3E44D0D082Q37333504-B4F0A9C2-F071-43A8-8FFF-23B959D3A618Q38108315-68DDF81A-2EC4-4C23-B525-3B4DE52906DEQ38830017-8D933994-3FE6-472A-836D-5FEDAFD42195Q40173450-825918D0-B67F-45AD-A087-9E0D0AA2EEE9Q40267788-4D0998E2-0FFB-4A2D-8CB4-3591386DE615Q40681919-45A2F97D-7CF9-4A03-BE65-9B96CB8A3F2DQ41004975-DF43414A-9EDA-4C7D-A635-F8CDED6D16F3Q41952624-7F0B5134-0479-4F53-9D6E-FA159EED7917Q47406070-79290768-958B-487C-AA36-4F5CD91C279BQ52610696-ED45F018-4B9F-4D5C-8AE1-508FED045620
P2860
Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Selective inhibition of COX-2 ...... not in bacterial peritonitis.
@en
Selective inhibition of COX-2 ...... not in bacterial peritonitis.
@nl
type
label
Selective inhibition of COX-2 ...... not in bacterial peritonitis.
@en
Selective inhibition of COX-2 ...... not in bacterial peritonitis.
@nl
prefLabel
Selective inhibition of COX-2 ...... not in bacterial peritonitis.
@en
Selective inhibition of COX-2 ...... not in bacterial peritonitis.
@nl
P2093
P2860
P1476
Selective inhibition of COX-2 ...... not in bacterial peritonitis.
@en
P2093
Peters-Golden M
Standiford TJ
P2860
P304
P356
10.1152/AJPLUNG.2001.281.3.L537
P577
2001-09-01T00:00:00Z